The Valvular Interventions Center

Filter Your Results

Meril’s Myval Transcatheter Heart Valve Receives CE Mark Approval

June 10, 2019 -- Meril Life Sciences Pvt. Ltd. recently announced it has received European CE Mark approval for the company's Myval transcatheter heart valve (THV) system …

Edwards Reports on Pascal TMVR System Clinical Studies

May 22, 2019 -- Edwards Lifesciences announced strategic clinical and regulatory milestones for the company's Pascal transcatheter valve repair system. The Pascal system r…

TRILUMINATE Study Evaluates Abbott's Tricuspid Valve Repair System

May 21, 2019 -- Abbott announced data from its TRILUMINATE study of the company's minimally invasive tricuspid valve repair system. The results were presented in a late-br…

LRT Trial Evaluates TAVR in Low-Risk Patients at 1 Year

May 20, 2019 -- The 1-year results of transcatheter aortic valve replacement (TAVR) in the Low-Risk TAVR (LRT) trial were published by Ron Waksman, MD, et al in Journal of the…

Simultaneous Measurement of Differential Pressures With a Dual Lumen Catheter

Christian Bradaric, MD

March/April 2019—Using a dual lumen catheter to accurately measure pressures between two sites across a valve or stenosis.

FIH Studies Completed for Pi-Cardia's Leaflex Performer Catheter to Treat Aortic Stenosis

May 7, 2019 -- Israel-based Pi-Cardia Ltd. announced the completion of first-in-human (FIH) studies with the company's Leaflex Performer catheter. Two sequential FIH studi…

Looking Ahead

Azeem Latib, MD

March/April 2019— It is with huge pleasure and honor that I take over the medical leadership of Cardiac Interventions Today, a publication that I have had the privilege of working with for …

Perspectives in TAVR

Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC; and Samir Kapadia, MD, FACC, FSCAI

March/April 2019— Transcatheter aortic valve replacement (TAVR) continues to undergo rapid and significant evolution. The recent announcement of data

...

111

Trends in United States TAVR Practice

An update on where TAVR is going as the technology matures in the United States.

By John C. Messenger, MD

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

Transcatheter Leaflet Repair for Functional MR

What will randomized trials mean for the future of mitral intervention?

By Ted Feldman, MD, FESC, FACC, MSCAI; Paul Sorajja, MD, FACC, FSCAI; Paul Grayburn, MD, FACC, FSCAI; and Francesco Maisano, MD

Trends in European TAVI Practice

Current application of TAVI in Europe.

By Giuliano Costa, MD; Marco Barbanti, MD; and Corrado Tamburino, MD, PhD

An Update on Transcatheter Tricuspid Valve Therapies

A review of the current state of transcatheter tricuspid valve therapies and where they are headed next.